PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New study finds recovery is still possible for critically endangered Hawaiian honeycreeper with urgent intervention

Latest Genomic Research offers a unique lens for understanding the extinction crisis in Hawai'i

2025-05-29
(Press-News.org)

CONTACT:          
San Diego Zoo Wildlife Alliance
Public Relations
619-685-3291 
publicrelations@sdzwa.org
sdzwa.org

PHOTOS AND VIDEO: https://sandiegozoo.box.com/s/uzfr25f5xzcgxyj0tgww5ob6nvafuyng

NEWS RELEASE

New Study Finds Recovery Is Still Possible for Critically Endangered Hawaiian Honeycreeper With Urgent Intervention Latest Genomic Research Offers a Unique Lens for Understanding the Extinction Crisis in Hawai‘i

SAN DIEGO (May 29, 2025) – A new scientific study, led by San Diego Zoo Wildlife Alliance, Smithsonian’s National Zoo & Conservation Biology Institute, and additional researchers, offers a unique lens for understanding the unprecedented extinction crisis of native Hawaiian forest birds. Just 17 out of approximately 60 species of the iconic honeycreeper remain, most of which are facing rapid decline due to avian malaria. The findings, published today in Current Biology, include new evidence that there is still time to save the critically endangered honeycreeper ‘akeke‘e—but the window is rapidly closing. 

“In a race against time to save the remaining honeycreepers, necessary insights about their survival are found in their genetic makeup,” said Christopher Kyriazis, Ph.D., lead author and postdoctoral researcher from San Diego Zoo Wildlife Alliance. “Our findings provide a new understanding of the last remaining individuals as recovery efforts forge on in their native forests and in human care.” 

Warming temperatures have enabled non-native mosquitos, the vectors of avian malaria, to spread further up the mountains. This leaves little to no refuge for Hawaiian honeycreepers, which lack immunity to malaria. The effects of avian malaria have been especially devastating on Kaua‘i island, which lacks high elevation habitats. Two critically endangered honeycreeper species endemic to Kaua‘i, the ‘akikiki and ‘akeke‘e, have faced population declines of more than 99% in the past two decades. Efforts to control mosquito populations by releasing reproductively incompatible male mosquitos are currently ongoing.

There are estimated to be less than 100 individual ‘akeke‘e remaining. Meanwhile, ‘akikiki are extinct in the wild, and the only remaining hope for the species is through a conservation breeding program of approximately 40 individuals at the Maui and Keauhou Bird Conservation Centers, operated by San Diego Zoo Wildlife Alliance. Through genomic analysis of three honeycreeper species, the ‘akikiki and ‘akeke‘e, and the extinct po‘ouli, researchers provide a detailed examination of genomic diversity, inbreeding depression and extinction risk.

Key findings:

There is still time to save the ‘akeke‘e from extinction: Under current conditions, ‘akeke‘e are likely to go extinct in the near future. However, if ongoing mosquito control efforts are successful, recovery is still possible.  Avian malaria is driving population collapse: Recent steep declines in ‘akikiki and ‘akeke‘e coincide with the spread of avian malaria in the late 20th century, consistent with malaria being the primary driver of population collapse.  Hawaiian honeycreepers maintain high genetic diversity: Hawaiian honeycreepers, even the last known po‘ouli individual, maintain high genetic diversity despite being critically endangered. While high genetic diversity may increase their potential to adapt to threats, it could also increase their vulnerability to inbreeding depression as population sizes decline at a rapid rate.  Inbreeding depression is already happening in ‘akikiki: Findings suggest that many of the founders of the conservation breeding program—‘akikiki brought into human care in a last-ditch effort to prevent extinction—are the offspring of related parents. Inbred birds produced fewer offspring and had lower survival. This information can be used to improve mate selection and further inform breeding decisions. 

The research offers a unique window into the genomic consequences of massive species decline and provides critical insight into how the damaging genetic factors, such as inbreeding depression, further exacerbate extinction risk. Findings will inform ongoing recovery efforts with the aim of averting extinction in the remaining honeycreeper species. 

Insights from the genome of the extinct po‘ouli underscore the importance of biobanking. In 2004, San Diego Zoo Wildlife Alliance established a cell line from the last living po‘ouli. Those cells were the first viable material from an extinct species to be cryopreserved, and they remained dormant in the Frozen Zoo® until recently, when researchers thawed one precious vial. Sequencing the po‘ouli genome, as seen in this study, provides evolutionary and genetic information that can benefit the conservation of other critically endangered Hawaiian forest birds. 

“We will never hear the po‘ouli honeycreeper’s song again, but we can learn from its genetic code,” said Oliver Ryder, Ph.D., director of conservation genetics at San Diego Zoo Wildlife Alliance. 

###

About San Diego Zoo Wildlife Alliance’s Frozen Zoo®
The Frozen Zoo® is the world’s first large-scale cryogenic biological bank dedicated to preserving living cells and reproductive material from wildlife—and remains the largest, most diverse collection of its kind. Founded in 1975 by Kurt Benirschke, M.D., the Frozen Zoo today holds cell lines from more than 11,500 individuals representing more than 1,300 species. Stored in liquid nitrogen at minus 320 degrees Fahrenheit, the collection includes cells, embryos and gametes from mammals, birds, reptiles, amphibians and fish. The Frozen Zoo is one of six unique San Diego Zoo Wildlife Alliance biobanking collections that make up its Wildlife Biodiversity Bank. Together these collections offer a variety of approaches to preserving biodiversity. Learn more at sdzwa.org/frozen-zoo. 

About San Diego Zoo Wildlife Alliance 
San Diego Zoo Wildlife Alliance, a nonprofit conservation leader, inspires passion for nature and collaboration for a healthier world. The Alliance supports innovative conservation science through global partnerships and groundbreaking efforts at the world-famous San Diego Zoo and San Diego Zoo Safari Park, both leading zoological institutions and accredited botanical gardens. Through wildlife care expertise, cutting-edge science and continued collaboration, more than 44 endangered species have been reintroduced to native habitats. The Alliance reaches over 1 billion people annually through its two conservation parks and media channels in 170 countries, including San Diego Zoo Wildlife Explorers television, available in children’s hospitals across 14 countries. Wildlife Allies—members, donors and guests—make success possible. 

END



ELSE PRESS RELEASES FROM THIS DATE:

All-in-one model reconstructs complex liver architecture

2025-05-29
To the point: New tissue-derived organoid model: A next-generation organoid model, composed of three liver cell types – adult hepatocytes, cholangiocytes, and liver mesenchymal cells – reconstructs the liver periportal region. Organoid functionality: The complex organoids, or assembloids, are functional, consistently draining bile from the bile canaliculi into the bile duct as in the real liver due to their accurate tissue architecture recapitulation. Liver disease modelling: This liver model reconstructs the liver periportal region architecture, is able to model aspects of cholestatic liver injury and biliary ...

Most Americans unaware of cancer risks associated with drinking alcohol

2025-05-29
Despite established connections, study finds almost 60% of U.S. adults are unaware or uncertain of the link between alcohol and cancer  An estimated 75,000 cancer cases are associated with alcohol annually in the U.S.  Researchers suggest implementing new Surgeon General recommendations could be an effective approach to reducing future cancer rates  HOUSTON, MAY 29, 2025 ― Alcohol is a leading preventable cause of cancer, but public awareness of the connection remains strikingly low in the U.S., with ...

New insights into bladder cancer treatment could help improve immunotherapies

2025-05-29
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer. Now, a team of researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) and is expanding the understanding of how the treatment works — an understanding that could help improve the effectiveness of immunotherapies more broadly. BCG is a weakened strain of the bacterium Mycobacterium bovis, which is ...

HIV discovery could open door to long-sought cure

2025-05-29
University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure: Their research shows that small changes in the virus affect how quickly or slowly it replicates, and how easily or stubbornly it can reawaken from hiding. These insights bring researchers closer to finding ways to flush out the dormant virus and eliminate it for good. Thanks to remarkable progress in HIV treatment, the virus can often be suppressed to undetectable levels in the blood, eliminating most disease symptoms, and preventing transmission to others. But HIV never truly ...

The purrfect gene

2025-05-29
Kyoto, Japan -- Whether you are lucky enough to have a cat companion or must merely live this experience vicariously through cat videos, Felis catus is a familiar and comforting presence in our daily lives. Unlike most other feline species, cats exhibit sociality, can live in groups, and communicate both with other cats and humans, which is why they have been humans' trusted accomplices for millennia. Despite this intimacy, there is still much that we don't know about our feline friends. Numerous behavioral studies have been conducted on other mammal species, but relatively few on cats. In part to fill this gap, a team of researchers at ...

Researchers find promise in a new peptide drug to combat a deadly brain cancer

2025-05-29
A lab-designed molecule developed and extensively studied by scientists with Virginia Tech’s Fralin Biomedical Research Institute at VTC could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer. In a study published in May in Cell Death and Disease, researchers identified a previously unknown trait of cancer cells that shows promise for therapeutic intervention. The group outlined the mechanism of action and effectiveness of the experimental drug known as JM2, revealing ...

Two WCM scientists receive inaugural Pershing Square Foundation Ovarian Cancer Challenge Grant

2025-05-29
(New York, May 29, 2025) – Dr. Juan R. Cubillos-Ruiz, the William J. Ledger, M.D. Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology, and Dr. David Lyden, the Stavros S. Niarchos Professor in Pediatric Cardiology, both from Weill Cornell Medicine, have been named inaugural recipients of the Pershing Square Foundation’s 2025 Ovarian Cancer Challenge Grant. The challenge grant provides $750,000 in funding over three years to support innovative research into ovarian cancer ...

Wyss Institute at Harvard University announces appointment of Natalie Artzi, Ph.D., to Associate Institute Director

2025-05-29
Wyss Institute at Harvard University Announces Appointment of Natalie Artzi, Ph.D.,  to Associate Institute Director Dr. Artzi will work closely with the Wyss Founding Director Don Ingber and the Wyss executive and senior leadership teams in shaping the strategic direction of the Institute  MAY 29,2025  – (Boston, MA) – The Wyss Institute at Harvard University, its Board of Directors, and Executive Leadership are pleased to announce that Natalie Artzi, Ph.D. has been appointed to a newly created position as Associate Institute Director ...

Earlier measles vaccine could help curb global outbreak

2025-05-29
The global measles outbreak must trigger an urgent debate into whether a vaccine should be recommended earlier to better protect against the highly contagious disease during infancy, a new review states. The systematic review, led by Murdoch Children’s Research Institute (MCRI), found vaccinating children from as early as four months of age for measles warranted serious discussion given that only 30 per cent of babies in low- and middle-income countries were protected by maternal antibodies by four months of age. Concerningly, this is well below the World Health Organization’s (WHO) recommendation of a first measles dose between 9-12 months old. The ...

Mixed-valence Cu-based metal-organic framework enables highly efficient CO2 electroreduction to C1 liquid fuels

2025-05-29
Rising atmospheric CO2 levels from fossil fuel dependence have intensified climate threats, driving demand for technologies that convert CO2 into value-added chemicals. Electrocatalytic CO2 reduction (CO2RR) holds promise but faces challenges such as high energy costs, low product selectivity, and competition from hydrogen evolution reactions (HER). A breakthrough by researchers at Tongji University, China, introduces a new catalyst design that overcomes these limitations, paving the way for green chemistry solutions.   The ...

LAST 30 PRESS RELEASES:

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

[Press-News.org] New study finds recovery is still possible for critically endangered Hawaiian honeycreeper with urgent intervention
Latest Genomic Research offers a unique lens for understanding the extinction crisis in Hawai'i